Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Inman

Showing results (131-140 of 258) with videos related to

Pageof 26
Sort By:
Rheumatology Advances in Practice|January 31, 2025
Impact of disease manifestations on first biologic drug survival in axial spondyloarthritis: a real-life Canadian studyRaphaël Hurtubise, Sherry Rohekar, Nigil Haroon, et al.
Annals of the Rheumatic Diseases|July 30, 2013
Serum levels of novel noggin and sclerostin-immune complexes are elevated in ankylosing spondylitisFlorence W L Tsui, Hing Wo Tsui, Facundo Las Heras, et al.
Arthritis and Rheumatism|October 29, 2011
Radiographic severity of ankylosing spondylitis is associated with polymorphism of the large multifunctional peptidase 2 gene in the Spondyloarthritis Research Consortium of Canada cohortNigil Haroon, Walter P Maksymowych, Proton Rahman, et al.
Rheumatology (Oxford, England)|December 13, 2021
Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline resultsDenis Poddubnyy, Joachim Sieper, Servet Akar, et al.
Arthritis Care & Research|March 14, 2020
Tumor Necrosis Factor Inhibitor Dose Reduction for Axial Spondyloarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsDaeria O Lawson, Maria Eraso, Lawrence Mbuagbaw, et al.
Rheumatology International|November 11, 2006
Altered host:pathogen interactions conferred by the Blau syndrome mutation of NOD2Tae-Hwan Kim, Ursula Payne, Xiang Zhang, et al.
The Journal of Biological Chemistry|November 9, 2002
Differential role of actin, clathrin, and dynamin in Fc gamma receptor-mediated endocytosis and phagocytosisShirley M L Tse, Wendy Furuya, Elizabeth Gold, et al.
Rheumatology (Oxford, England)|October 2, 2012
Comparison of three enthesitis indices in a multicentre, randomized, placebo-controlled trial of golimumab in ankylosing spondylitis (GO-RAISE)Désirée van der Heijde, Jürgen Braun, Atul Deodhar, et al.
Annals of the Rheumatic Diseases|July 28, 2011
Measuring participation in people with spondyloarthritis using the social role participation questionnaireAileen M Davis, Marvilyn P Palaganas, Elizabeth M Badley, et al.
Arthritis and Rheumatism|November 1, 2008
Toll-like receptor 2 variants are associated with acute reactive arthritisFlorence W L Tsui, Nancy Xi, Sherry Rohekar, et al.
Pageof 26

Showing results (131-140 of 258) with videos related to

Sort By:
Pageof 26
Rheumatology Advances in Practice|January 31, 2025
Impact of disease manifestations on first biologic drug survival in axial spondyloarthritis: a real-life Canadian studyRaphaël Hurtubise, Sherry Rohekar, Nigil Haroon, et al.
Annals of the Rheumatic Diseases|July 30, 2013
Serum levels of novel noggin and sclerostin-immune complexes are elevated in ankylosing spondylitisFlorence W L Tsui, Hing Wo Tsui, Facundo Las Heras, et al.
Arthritis and Rheumatism|October 29, 2011
Radiographic severity of ankylosing spondylitis is associated with polymorphism of the large multifunctional peptidase 2 gene in the Spondyloarthritis Research Consortium of Canada cohortNigil Haroon, Walter P Maksymowych, Proton Rahman, et al.
Rheumatology (Oxford, England)|December 13, 2021
Characteristics of patients with axial spondyloarthritis by geographic regions: PROOF multicountry observational study baseline resultsDenis Poddubnyy, Joachim Sieper, Servet Akar, et al.
Arthritis Care & Research|March 14, 2020
Tumor Necrosis Factor Inhibitor Dose Reduction for Axial Spondyloarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsDaeria O Lawson, Maria Eraso, Lawrence Mbuagbaw, et al.
Rheumatology International|November 11, 2006
Altered host:pathogen interactions conferred by the Blau syndrome mutation of NOD2Tae-Hwan Kim, Ursula Payne, Xiang Zhang, et al.
The Journal of Biological Chemistry|November 9, 2002
Differential role of actin, clathrin, and dynamin in Fc gamma receptor-mediated endocytosis and phagocytosisShirley M L Tse, Wendy Furuya, Elizabeth Gold, et al.
Rheumatology (Oxford, England)|October 2, 2012
Comparison of three enthesitis indices in a multicentre, randomized, placebo-controlled trial of golimumab in ankylosing spondylitis (GO-RAISE)Désirée van der Heijde, Jürgen Braun, Atul Deodhar, et al.
Annals of the Rheumatic Diseases|July 28, 2011
Measuring participation in people with spondyloarthritis using the social role participation questionnaireAileen M Davis, Marvilyn P Palaganas, Elizabeth M Badley, et al.
Arthritis and Rheumatism|November 1, 2008
Toll-like receptor 2 variants are associated with acute reactive arthritisFlorence W L Tsui, Nancy Xi, Sherry Rohekar, et al.
Pageof 26